InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
57%
T+90 mean return
+15.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Parschauer Karah Herdman, Deputy Chief Executive. Director active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 23 reports have been logged. Split: 0 buy · 13 sells. Total volume traded: €1.8m. Activity tracked since 6 May 2021. The latest transaction was disclosed on 12 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations23 total
12,888 shares@ US$12.993951.5% of flowCommon StockSEC:0001570562-25-000046:0
7,364 shares0Common StockSEC:0001570562-25-000035:0
18,443 shares0Common StockSEC:0000950170-25-032798:0
▼
2,230 shares@ US$42.934.3% of flowCommon StockSEC:0000950170-25-030639:0
▼
9,806 shares@ US$45.0019.0% of flowCommon StockSEC:0000950170-24-072621:0
17,800 shares0Common StockSEC:0000950170-24-026666:0
6,464 shares0Common StockSEC:0001570562-24-000021:0
11,931 shares@ US$13.136648.5% of flowCommon StockSEC:0001570562-24-000005:0
▼
4,378 shares@ US$45.008.3% of flowCommon StockSEC:0001209191-23-027601:0
2,663 shares0Common StockSEC:0001209191-23-016047:0
8,293 shares0Common StockSEC:0001570562-23-000023:0
▼
5,140 shares@ US$62.950.012% mcap20.3% of flowCommon StockSEC:0001209191-22-016931:0
▼
2,886 shares@ US$66.620.0070% mcap11.7% of flowCommon StockSEC:0001209191-22-015811:0
15,568 shares0Common StockSEC:0001570562-22-000050
15,568 shares0Common StockSEC:0001570562-22-000050:0
▼
310 shares@ US$81.140.0009% mcap1.5% of flowCommon StockSEC:0001209191-21-060752:0
▼
310 shares@ US$81.141.0% of flowCommon StockSEC:0001209191-21-060752
◇
7,336 shares@ US$54.500.014% mcap23.1% of flowCommon StockSEC:0001209191-21-055362:0
◇
7,336 shares@ US$54.5015.8% of flowCommon StockSEC:0001209191-21-055362
▼
1,329 shares@ US$100.000.0044% mcap7.4% of flowCommon StockSEC:0001209191-21-040108:0
▼
1,329 shares@ US$100.005.1% of flowCommon StockSEC:0001209191-21-040108
▼
313 shares@ US$113.672.0% of flowCommon StockSEC:0001209191-21-031388
▼
313 shares@ US$113.670.0012% mcap2.0% of flowCommon StockSEC:0001209191-21-031388:0
23 of 23 declarations
About Parschauer Karah Herdman
Karah Herdman Parschauer is the Executive Vice President and General Counsel at Ultragenyx Pharmaceutical Inc. She oversees the company's legal and regulatory matters, ensuring that operations comply with applicable laws. With a strong background in the pharmaceutical sector, she plays a key role in risk management and the company's legal strategy. Her expertise is essential for navigating a complex regulatory environment.
